325 related articles for article (PubMed ID: 27017410)
1. Characteristics of breast cancer in Central China, literature review and comparison with USA.
Chen C; Sun S; Yuan JP; Wang YH; Cao TZ; Zheng HM; Jiang XQ; Gong YP; Tu Y; Yao F; Hu MB; Li JJ; Sun SR; Wei W
Breast; 2016 Dec; 30():208-213. PubMed ID: 27017410
[TBL] [Abstract][Full Text] [Related]
2. A clinical database of breast cancer patients reveals distinctive clinico-pathological characteristics: a study from central China.
Wang LW; Yang GF; Chen JM; Yang F; Yuan JP; Sun SR; Chen C; Hu MB; Li Y
Asian Pac J Cancer Prev; 2014; 15(4):1621-6. PubMed ID: 24641378
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer in Chinese women younger than age 40: are they different from their older counterparts?
Kwong A; Cheung P; Chan S; Lau S
World J Surg; 2008 Dec; 32(12):2554-61. PubMed ID: 18408960
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
5. A comparison of Chinese multicenter breast cancer database and SEER database.
Niu Y; Zhang F; Chen D; Ye G; Li Y; Zha Y; Chen W; Liu D; Liao X; Huang Q; Tang W; Cai G; Guo R; Li H; Tang S
Sci Rep; 2022 Jun; 12(1):10395. PubMed ID: 35729333
[TBL] [Abstract][Full Text] [Related]
6. Young onset breast cancer in Southern China - a 5-year clinico-pathological study from a multi-centre database.
Co M; Kwong A
Cancer Treat Res Commun; 2020; 24():100182. PubMed ID: 32534410
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Disparities: A Multicenter Comparison of Tumor Diagnosis, Characteristics, and Surgical Treatment in China and the U.S.
Sivasubramaniam PG; Zhang BL; Zhang Q; Smith JS; Zhang B; Tang ZH; Chen GJ; Xie XM; Xu XZ; Yang HJ; He JJ; Li H; Li JY; Fan JH; Qiao YL
Oncologist; 2015 Sep; 20(9):1044-50. PubMed ID: 26240131
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001.
Kwong A; Mang OW; Wong CH; Chau WW; Law SC;
Ann Surg Oncol; 2011 Oct; 18(11):3072-8. PubMed ID: 21847700
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
Roberts MC; Miller DP; Shak S; Petkov VI
Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
[TBL] [Abstract][Full Text] [Related]
10. Female breast cancer incidence among Asian and Western populations: more similar than expected.
Sung H; Rosenberg PS; Chen WQ; Hartman M; Lim WY; Chia KS; Wai-Kong Mang O; Chiang CJ; Kang D; Ngan RK; Tse LA; Anderson WF; Yang XR
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25868578
[TBL] [Abstract][Full Text] [Related]
11. Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population.
Lin CH; Yap YS; Lee KH; Im SA; Naito Y; Yeo W; Ueno T; Kwong A; Li H; Huang SM; Leung R; Han W; Tan B; Hu FC; Huang CS; Cheng AL; Lu YS;
J Natl Cancer Inst; 2019 Dec; 111(12):1298-1306. PubMed ID: 31093668
[TBL] [Abstract][Full Text] [Related]
12. Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain.
AlZaman AS; Mughal SA; AlZaman YS; AlZaman ES
Saudi Med J; 2016 Jan; 37(1):37-42. PubMed ID: 26739972
[TBL] [Abstract][Full Text] [Related]
13. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI
Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948
[TBL] [Abstract][Full Text] [Related]
14. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
Wei JL; Zhang JX; Fu DY
World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan.
Wong KC; Wang Z
Diabetes Res Clin Pract; 2006 Aug; 73(2):126-34. PubMed ID: 16563548
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
Zhu X; Ying J; Wang F; Wang J; Yang H
Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
[TBL] [Abstract][Full Text] [Related]
17. [Characterization of hormone receptor status in 5758 Chinese females with breast cancer].
Gao JD; Wang J; Feng XL; Zhong YX; Wang X
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):683-6. PubMed ID: 20021865
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
Li FY; Wu SG; Zhou J; Sun JY; Lin Q; Lin HX; Guan XX; He ZY
PLoS One; 2014; 9(2):e87264. PubMed ID: 24498305
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer age at diagnosis patterns in four Latin American Populations: A comparison with North American countries.
Franco-Marina F; López-Carrillo L; Keating NL; Arreola-Ornelas H; Marie Knaul F
Cancer Epidemiol; 2015 Dec; 39(6):831-7. PubMed ID: 26651442
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Outcomes of CNS Tumors in Chinese Children: Comparative Analysis With the Surveillance, Epidemiology, and End Results Program.
Liu APY; Liu Q; Shing MMK; Ku DTL; Fu E; Luk CW; Ling SC; Cheng KKF; Kwong DLW; Ho WWS; Ng HK; Gajjar A; Yasui Y; Chan GCF; Armstrong GT
JCO Glob Oncol; 2020 May; 6():704-721. PubMed ID: 32392090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]